Espeso-Gil Genome medicine 2020 (Pubmed ID 32075678)

syn22352305

Created By Kelsey Montgomery kelsey

DOI: 10.1186/s13073-020-0715-x
year: 2020
study: DopaModel
title: A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons.
grants: U01DA048279 R01DA047880
authors: Espeso-Gil S, Halene T, Bendl J, Kassim B, Ben Hutta G, Iskhakova M, Shokrian N, Auluck P, Javidfar B, Rajarajan P, Chandrasekaran S, Peter CJ, Cote A, Birnbaum R, Liao W, Borrman T, Wiseman J, Bell A, Bannon MJ, Roussos P, Crary JF, Weng Z, Marenco S, Lipska B, Tsankova NM, Huckins L, Jiang Y, Akbarian S
journal: Genome medicine
abstract: Midbrain dopaminergic neurons (MDN) represent 0.0005% of the brain's neuronal population and mediate cognition, food intake, and metabolism. MDN are also posited to underlay the neurobiological dysfunction of schizophrenia (SCZ), a severe neuropsychiatric disorder that is characterized by psychosis as well as multifactorial medical co-morbidities, including metabolic disease, contributing to markedly increased morbidity and mortality. Paradoxically, however, the genetic risk sequences of psychos
pubmedId: 32075678
entity_name: Espeso-Gil Genome medicine 2020 (Pubmed ID 32075678)

Espeso-Gil Genome medicine 2020 (Pubmed ID 32075678) page is loading…